W
bioLLM/wiki

AI-Curated Biotech/Medical Knowledge Base
Live
Back to List View Graph View

COVID-19 vaccine

The COVID-19 vaccine is a pharmaceutical intervention designed to elicit an immune response against the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), the virus responsible for the COVID-19 pandemic.

Where the papers sit

28 papers from the last 6 months study COVID-19 vaccine directly · updated from PubMed 9 Oct 2026

Study type 1 clinical trial · 11 observational · 16 human data

Themes one subject

Those 28 are all about one subject.

  • COVID-19 Vaccination Outcomes

    Vaccination research links uptake and protection to access, sociodemographic factors, trust, and health-system policy. Rural populations, pregnant women, older adults, people with HIV, and other underserved groups recur across the evidence. Real-world studies track reactogenicity, hospitalisation, mortality, coverage, and vaccine effectiveness, while qualitative work highlights cold-chain and sociocultural barriers. The field remains focused on equitable delivery and reliable evaluation rather than one unified intervention.

    28 papers

Papers

The 28 papers from the last 6 months that study COVID-19 vaccine directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

COVID-19 Vaccination Outcomes (28)
  1. Predictors of COVID-19 vaccination status among youth in eThekwini, South Africa: results from the AYAZAZI RIGHTS study. Global health action · 6 Oct 2026 PMID 42834877
  2. Real-world evaluation of 2023-2024 XBB.1.5 mRNA and protein-based COVID-19 vaccine reactogenicity from the randomized BEEHIVE trial. Human vaccines & immunotherapeutics · 30 Sept 2026 PMID 42811742
  3. Payers should cover COVID-19 vaccines for all ages and risk groups with no patient cost sharing. Journal of managed care & specialty pharmacy · 29 Sept 2026 PMID 42808541
  4. Availability and accessibility of SARS-CoV-2 vaccines among rural populations in sub-Saharan Africa: a systematic review and meta-analysis protocol. BMJ open · 24 Sept 2026 PMID 42785944
  5. Sociodemographic and Lifestyle Factors Associated With COVID-19 Vaccine Uptake in a Mixed Urban-Rural Population in Eastern Poland. Medical science monitor : international medical journal of experimental and clinical research · 23 Sept 2026 PMID 42776929
  6. COVID-19 mortality risk among people with HIV in Florida before and after the introduction of COVID-19 vaccines: A population-based study. PloS one · 18 Sept 2026 PMID 42758717
  7. Are both COVID-19 and COVID-19 vaccines associated with cancer? Oncotarget · 11 Sept 2026 PMID 42725534
  8. A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women. Vaccine · 29 Aug 2026 PMID 42667899
  9. Effectiveness of coronavirus disease 2019 (COVID-19) original vaccines to prevent COVID-19-related hospitalisations among Alaska Native peoples, January 2021-October 2022. International journal of circumpolar health · 22 Aug 2026 PMID 42632078
  10. Lessons learnt from one-year cold chain support for COVID-19 vaccination in 5 middle income countries of North Africa. Vaccine · 18 Aug 2026 PMID 42612463
  11. COVID-19 vaccination among people affected by sexually transmitted and bloodborne infections, methamphetamine use and their intersection in Manitoba, Canada: a retrospective matched cohort analysis using population-based administrative healthcare data (2020-2022). BMJ open · 12 Aug 2026 PMID 42586735
  12. Why COVID-19 vaccination struggled in the Democratic Republic of Congo: a qualitative study exploring organizational and sociocultural barriers, 2025. Vaccine · 12 Aug 2026 PMID 42585810
  13. Healthy vaccinee effect in the evaluation of updated COVID-19 vaccines in elderly populations. Nature communications · 8 Aug 2026 PMID 42570961
  14. Partisan differences in healthcare decision-making: Evidence from a vaccine experiment. PloS one · 20 Jul 2026 PMID 42475322
  15. The Relationship Between COVID-19 Vaccine Regret, Distrust of the Healthcare System, and Future Vaccine Intentions. Journal of evaluation in clinical practice · 19 Jul 2026 PMID 42472384
  16. Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024. Vaccine · 2 Jul 2026 PMID 42391690
  17. V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023. Vaccine · 30 Jun 2026 PMID 42378925
  18. Caregiver COVID-19 vaccine status and its influence on pediatric vaccination decisions in a US cohort. Vaccine · 17 Jun 2026 PMID 42308977
  19. Partisan and Geographic Variation in Emotional Responses to COVID-19 Vaccination on Social Media. JAMA network open · 1 Jun 2026 PMID 42223941
  20. Online Information Behavior Regarding COVID-19 Vaccination and Its Association With Vaccination Behavior Based on Cluster Analysis of User Groups: Cross-Sectional Study. JMIR infodemiology · 29 May 2026 PMID 42214069
  21. Prevalence and correlates of COVID-19 vaccine uptake among sexual and gender minority adolescents in the southern United States. Vaccine · 9 May 2026 PMID 42105394
  22. Trends in socio-demographic disparities in COVID-19 vaccine uptake by vaccine dose and time after the introduction of COVID-19 vaccination in Israel: epidemiological and policy analysis study. Israel journal of health policy research · 3 May 2026 PMID 42071245
  23. Language and racial disparities in COVID-19 vaccination during pregnancy and lactation. Vaccine · 2 May 2026 PMID 42068907
  24. Safety of COVID-19 and influenza vaccines in children and adolescents with immunocompromised or autoimmune conditions: Findings from the Canadian National Vaccine Safety (CANVAS) network. Human vaccines & immunotherapeutics · 29 Apr 2026 PMID 42053343
  25. Surveillance of adverse events following immunisation in Australia, 2023. Communicable diseases intelligence (2018) · 28 Apr 2026 PMID 42048781
  26. Effectiveness of COVID-19 vaccine booster doses in adults aged 50 years and over during the Omicron period in Victoria, Australia. Communicable diseases intelligence (2018) · 28 Apr 2026 PMID 42048780
  27. Strengthening access to and confidence in COVID-19 vaccines among equity-deserving populations across Canada: An exploratory qualitative study. PloS one · 27 Apr 2026 PMID 42044194
  28. Parental attitudes and factors associated with COVID-19 vaccination for toddlers in Japan: a questionnaire survey in Toyonaka city. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 17 Apr 2026 PMID 41997485

By study type

Clinical trials (1)
  1. Real-world evaluation of 2023-2024 XBB.1.5 mRNA and protein-based COVID-19 vaccine reactogenicity from the randomized BEEHIVE trial. Human vaccines & immunotherapeutics · 30 Sept 2026 PMID 42811742
Observational studies and case reports (11)
  1. Predictors of COVID-19 vaccination status among youth in eThekwini, South Africa: results from the AYAZAZI RIGHTS study. Global health action · 6 Oct 2026 PMID 42834877
  2. Sociodemographic and Lifestyle Factors Associated With COVID-19 Vaccine Uptake in a Mixed Urban-Rural Population in Eastern Poland. Medical science monitor : international medical journal of experimental and clinical research · 23 Sept 2026 PMID 42776929
  3. A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women. Vaccine · 29 Aug 2026 PMID 42667899
  4. Effectiveness of coronavirus disease 2019 (COVID-19) original vaccines to prevent COVID-19-related hospitalisations among Alaska Native peoples, January 2021-October 2022. International journal of circumpolar health · 22 Aug 2026 PMID 42632078
  5. COVID-19 vaccination among people affected by sexually transmitted and bloodborne infections, methamphetamine use and their intersection in Manitoba, Canada: a retrospective matched cohort analysis using population-based administrative healthcare data (2020-2022). BMJ open · 12 Aug 2026 PMID 42586735
  6. The Relationship Between COVID-19 Vaccine Regret, Distrust of the Healthcare System, and Future Vaccine Intentions. Journal of evaluation in clinical practice · 19 Jul 2026 PMID 42472384
  7. Caregiver COVID-19 vaccine status and its influence on pediatric vaccination decisions in a US cohort. Vaccine · 17 Jun 2026 PMID 42308977
  8. Partisan and Geographic Variation in Emotional Responses to COVID-19 Vaccination on Social Media. JAMA network open · 1 Jun 2026 PMID 42223941
  9. Online Information Behavior Regarding COVID-19 Vaccination and Its Association With Vaccination Behavior Based on Cluster Analysis of User Groups: Cross-Sectional Study. JMIR infodemiology · 29 May 2026 PMID 42214069
  10. Language and racial disparities in COVID-19 vaccination during pregnancy and lactation. Vaccine · 2 May 2026 PMID 42068907
  11. Safety of COVID-19 and influenza vaccines in children and adolescents with immunocompromised or autoimmune conditions: Findings from the Canadian National Vaccine Safety (CANVAS) network. Human vaccines & immunotherapeutics · 29 Apr 2026 PMID 42053343
Human data, design not indexed (16)
  1. Payers should cover COVID-19 vaccines for all ages and risk groups with no patient cost sharing. Journal of managed care & specialty pharmacy · 29 Sept 2026 PMID 42808541
  2. Availability and accessibility of SARS-CoV-2 vaccines among rural populations in sub-Saharan Africa: a systematic review and meta-analysis protocol. BMJ open · 24 Sept 2026 PMID 42785944
  3. COVID-19 mortality risk among people with HIV in Florida before and after the introduction of COVID-19 vaccines: A population-based study. PloS one · 18 Sept 2026 PMID 42758717
  4. Are both COVID-19 and COVID-19 vaccines associated with cancer? Oncotarget · 11 Sept 2026 PMID 42725534
  5. Lessons learnt from one-year cold chain support for COVID-19 vaccination in 5 middle income countries of North Africa. Vaccine · 18 Aug 2026 PMID 42612463
  6. Why COVID-19 vaccination struggled in the Democratic Republic of Congo: a qualitative study exploring organizational and sociocultural barriers, 2025. Vaccine · 12 Aug 2026 PMID 42585810
  7. Healthy vaccinee effect in the evaluation of updated COVID-19 vaccines in elderly populations. Nature communications · 8 Aug 2026 PMID 42570961
  8. Partisan differences in healthcare decision-making: Evidence from a vaccine experiment. PloS one · 20 Jul 2026 PMID 42475322
  9. Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024. Vaccine · 2 Jul 2026 PMID 42391690
  10. V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023. Vaccine · 30 Jun 2026 PMID 42378925
  11. Prevalence and correlates of COVID-19 vaccine uptake among sexual and gender minority adolescents in the southern United States. Vaccine · 9 May 2026 PMID 42105394
  12. Trends in socio-demographic disparities in COVID-19 vaccine uptake by vaccine dose and time after the introduction of COVID-19 vaccination in Israel: epidemiological and policy analysis study. Israel journal of health policy research · 3 May 2026 PMID 42071245
  13. Surveillance of adverse events following immunisation in Australia, 2023. Communicable diseases intelligence (2018) · 28 Apr 2026 PMID 42048781
  14. Effectiveness of COVID-19 vaccine booster doses in adults aged 50 years and over during the Omicron period in Victoria, Australia. Communicable diseases intelligence (2018) · 28 Apr 2026 PMID 42048780
  15. Strengthening access to and confidence in COVID-19 vaccines among equity-deserving populations across Canada: An exploratory qualitative study. PloS one · 27 Apr 2026 PMID 42044194
  16. Parental attitudes and factors associated with COVID-19 vaccination for toddlers in Japan: a questionnaire survey in Toyonaka city. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 17 Apr 2026 PMID 41997485
bioLLM/wiki is a literature-navigation aid for people who read primary research. It is not a medical resource, and it is not a substitute for a clinician, a pharmacist or the source papers themselves. Because the articles are drafted by language models, they can be incomplete or wrong in ways that read fluently. Please see the editorial policy and medical disclaimer before relying on anything here.

Written from 28 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-09-26 by GPT. Drafted by language models from published abstracts; not medical advice.